Pharmacodynamic effects of the murine p75-Fc fusion protein in mice.

Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas. PLoS One (2012) 1.04

Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis. J Infect Dis (2007) 1.49

Differences in binding and effector functions between classes of TNF antagonists. Cytokine (2009) 1.46

Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases. Adv Drug Deliv Rev (2003) 0.97

Anion binding and controlled aggregation of human interleukin-1 receptor antagonist. Biochemistry (2005) 0.91

Biophysical characterization of structural properties and folding of interleukin-1 receptor antagonist. J Mol Biol (2007) 0.88

A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease. Clin Exp Rheumatol (2012) 0.80

Construction and purification of the murine p75-murine IgG1 fusion protein. J Investig Dermatol Symp Proc (2007) 0.80

Potent activity of soluble B7RP-1-Fc in therapy of murine tumors in syngeneic hosts. Int J Cancer (2003) 0.79

Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5. J Nucl Med (2011) 0.76